Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples

被引:308
作者
Yankeelov, Thomas E.
Gore, John C.
机构
[1] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA
[4] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA
[5] Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA
关键词
DCE-MRI; pharmacokinetics; cancer; compartmental modeling; contrast agent;
D O I
10.2174/157340507780619179
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Dynamic contrast enhanced MRI (DCE-MRI) enables the quantitative assessment of tumor status and has found application in both pre-clinical tumor models as well as clinical oncology. DCE-MRI requires the serial acquisition of images before and after the injection of a paramagnetic contrast agent so that the variation of MR signal intensity with time can be recorded for each image voxel. As the agent enters into a tissue, it changes the MR signal intensity from the tissue to a degree that depends on the local concentration. After the agent is transported out of the tissue, the MR signal intensity returns to its' baseline value. By analyzing the associated signal intensity time course using an appropriate mathematical model, physiological parameters related to blood flow, vessel permeability, and tissue volume fractions can be extracted for each voxel or region of interest. In this review we first discuss the basic physics of this methodology, and then present technical aspects of how DCE-MRI data are acquired and analyzed. We also discuss appropriate models of contrast agent kinetics and how these can be used to elucidate tissue characteristics of importance in cancer biology. We conclude by briefly summarizing some future goals and demands of DCE-MRI.
引用
收藏
页码:91 / 107
页数:17
相关论文
共 141 条
[1]  
Abragam A., 2002, PRINCIPLES NUCL MAGN
[2]   Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis [J].
Atkin, G. ;
Taylor, N. J. ;
Daley, F. M. ;
Stirling, J. J. ;
Richman, P. ;
Glynne-Jones, R. ;
d'Arcy, J. A. ;
Collins, D. J. ;
Padhani, A. R. .
BRITISH JOURNAL OF SURGERY, 2006, 93 (08) :992-1000
[3]   New technologies and directed agents for applications of cancer imaging [J].
Atri, Mostafa .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) :3299-3308
[4]  
Blakey DC, 2002, CLIN CANCER RES, V8, P1974
[5]   MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report [J].
Brasch, R ;
Turetschek, K .
EUROPEAN JOURNAL OF RADIOLOGY, 2000, 34 (03) :148-155
[6]   PHARMACOKINETIC PARAMETERS IN CNS GD-DTPA ENHANCED MR IMAGING [J].
BRIX, G ;
SEMMLER, W ;
PORT, R ;
SCHAD, LR ;
LAYER, G ;
LORENZ, WJ .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (04) :621-628
[7]   Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer [J].
Brown, J ;
Coulthard, A ;
Dixon, AK ;
Dixon, JM ;
Easton, DF ;
Eeles, RA ;
Evans, DGR ;
Gilbert, FG ;
Hayes, C ;
Jenkins, JPR ;
Leach, MO ;
Moss, SM ;
Padhani, AP ;
Pointon, LJ ;
Ponder, BAJ ;
Sloane, JP ;
Turnbull, LW ;
Walker, LG ;
Warren, RML ;
Watson, W .
BREAST, 2000, 9 (02) :78-82
[8]   Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study [J].
Brown, J ;
Buckley, D ;
Coulthard, A ;
Dixon, AK ;
Dixon, JM ;
Easton, DF ;
Eeles, RA ;
Evans, DGR ;
Gilbert, FG ;
Graves, M ;
Hayes, C ;
Jenkins, JPR ;
Jones, AP ;
Keevil, SF ;
Leach, MO ;
Liney, GP ;
Moss, SM ;
Padhani, AR ;
Parker, GJM ;
Pointon, LJ ;
Ponder, BAJ ;
Redpath, TW ;
Sloane, JP ;
Turnbull, LW ;
Walker, LG ;
Warren, RML .
MAGNETIC RESONANCE IMAGING, 2000, 18 (07) :765-776
[9]   Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI [J].
Buckley, DL .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (03) :601-606
[10]  
Bushberg JT., ESSENTIAL PHYS MED I, P359